CR8876A - 1,1,2,2-tetra(hetero)ariletanos 1,1,2-tri(hetero)-aril-2-heterocicloetanos como inhibidores de canales de potasio - Google Patents

1,1,2,2-tetra(hetero)ariletanos 1,1,2-tri(hetero)-aril-2-heterocicloetanos como inhibidores de canales de potasio

Info

Publication number
CR8876A
CR8876A CR8876A CR8876A CR8876A CR 8876 A CR8876 A CR 8876A CR 8876 A CR8876 A CR 8876A CR 8876 A CR8876 A CR 8876A CR 8876 A CR8876 A CR 8876A
Authority
CR
Costa Rica
Prior art keywords
hetero
inhibitors
heterocicloetanos
ariletanos
aril
Prior art date
Application number
CR8876A
Other languages
English (en)
Inventor
T Bilodeau Mark
Wu Zhicai
Hartnett John
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CR8876A publication Critical patent/CR8876A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a compuestos que tienen la estructura que se muestra, utiles como inhibidores del canal de potasio para tratar arritmias cardiacas y afecciones similares.
CR8876A 2004-07-29 2007-01-25 1,1,2,2-tetra(hetero)ariletanos 1,1,2-tri(hetero)-aril-2-heterocicloetanos como inhibidores de canales de potasio CR8876A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59218104P 2004-07-29 2004-07-29

Publications (1)

Publication Number Publication Date
CR8876A true CR8876A (es) 2007-08-28

Family

ID=35613661

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8876A CR8876A (es) 2004-07-29 2007-01-25 1,1,2,2-tetra(hetero)ariletanos 1,1,2-tri(hetero)-aril-2-heterocicloetanos como inhibidores de canales de potasio

Country Status (15)

Country Link
KR (1) KR20070043985A (es)
AR (1) AR049847A1 (es)
BR (1) BRPI0513793A (es)
CR (1) CR8876A (es)
EC (1) ECSP077208A (es)
IL (1) IL180846A0 (es)
MA (1) MA28980B1 (es)
MX (1) MX2007001188A (es)
NO (1) NO20071107L (es)
PE (1) PE20060382A1 (es)
RU (1) RU2344134C2 (es)
TW (1) TW200607493A (es)
UA (1) UA88018C2 (es)
WO (1) WO2006028590A1 (es)
ZA (1) ZA200700477B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2408440B1 (en) * 2009-03-18 2016-05-11 Medicure International Inc. Transdermal pharmaceutical preparation and administration of tirofiban
PT2858987T (pt) 2012-06-11 2018-07-04 Bristol Myers Squibb Co Profármacos de ácido fosforamídico de 5-[5-fenil-4-(piridin-2-ilmetilamino)quinazolin -2-il]piridina-3-sulfonamida

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2140865B2 (de) * 1971-08-14 1979-10-11 Bayer Ag, 5090 Leverkusen 1 -Imidazolyl-methanphosphonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE19951701A1 (de) * 1999-10-27 2001-05-03 Aventis Pharma Gmbh Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
EP1465863B1 (en) * 2002-01-04 2008-07-09 NeuroSearch A/S Potassium channel modulators

Also Published As

Publication number Publication date
MA28980B1 (fr) 2007-11-01
KR20070043985A (ko) 2007-04-26
MX2007001188A (es) 2007-03-21
RU2007107408A (ru) 2008-09-10
TW200607493A (en) 2006-03-01
NO20071107L (no) 2007-04-19
IL180846A0 (en) 2007-06-03
UA88018C2 (ru) 2009-09-10
PE20060382A1 (es) 2006-05-15
ECSP077208A (es) 2007-02-28
AR049847A1 (es) 2006-09-06
BRPI0513793A (pt) 2008-05-13
RU2344134C2 (ru) 2009-01-20
WO2006028590A1 (en) 2006-03-16
ZA200700477B (en) 2009-08-26

Similar Documents

Publication Publication Date Title
EA201270378A1 (ru) Хиназолины в качестве ингибиторов калиевых каналов
ECSP088676A (es) Pirazolquinolonas como potentes inhibidores de parp
NO20082298L (no) Kaliumkanalinhibitorer
ECSP088210A (es) Bencimidazoles sustituidos y métodos de preparación
JO2853B1 (en) Sulfonamides as TRPM8 organizations
UY32730A (es) Inhibidores de cyp17
NI201000126A (es) Arilpirrolinas insecticida.
CU20120071A7 (es) DERIVADOS DE N1-PIRAZOLOESPIROCETONA ÚTILES COMO INHIBIDORES DE ACETIL-CoA CARBOXILASA
GT200500102A (es) Compuestos de aril-o-heteroarilamida ortosustituidos
EA201500403A1 (ru) Соединения, активирующие теломеразу, и способы их применения
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
BRPI0519521A2 (pt) derivados de tieno-piridina como aumentadores alostÉricos gaba-b
UY31273A1 (es) Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53
EA201170344A1 (ru) Азаиндольные ингибиторы iap
PA8667201A1 (es) Nuevos compuestos farmaceuticos
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
BRPI0412636A (pt) imidazopirimidinas substituìdas para a prevenção e tratamento de cáncer
UY27772A1 (es) Inhibidores triariloxiariloxipirimidin-2,4,6- triona de metaloproteinasa.
BRPI0508594A (pt) moduladores de canal de ìon
BRPI0508522A (pt) moduladores de canal de ìon
CR8111A (es) Derivados sustituidos del pirrol
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
ECSP077208A (es) Inhibidores de los canales de potasio
BRPI0508550A (pt) moduladores de canal de ìon
CR11117A (es) Formulaciones orales controladas para la liberacion de los compuestos de modulacion del canal del ion y metodos relacionados para evitar arritmia

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)